In this issue:
DMT & disability progression in PPMS
D-Lay MS: high-dose vitamin D monotherapy in CIS
Anti-EBV therapies for investigation in MS
Feasibility of unified diagnostic criteria for MS
Additional cladribine courses in highly active RMS
Contribution of lesion accrual vs. brain atrophy in predicting SPMS
Smartphone-based gait analysis
Real-world experience of cladribine
Spinal cord lesion formation with high-vs.low-efficacy DMTs in relapse-onset MS
MOGADOC: prognostic value of CSF-OCBs in MOGAD
Please login below to download this issue (PDF)